Key result
VISTAQ-derived LGE over 10% is linked to a ~56-fold higher risk of hard cardiac events in HCM.
Why the study?
Conventional LGE quantification requires contour tracing and region-of-interest placement, which may reduce reproducibility and increase analysis time.
Does the VISTAQ method improve the reproducibility, time-efficiency, and prognostic accuracy of LGE quantification compared to conventional threshold-based techniques in patients with cardiac diseases?
Cohort (n=400)
Single-blind
Yes
Does the VISTAQ method improve the reproducibility, time-efficiency, and prognostic accuracy of LGE quantification compared to conventional threshold-based techniques in patients with cardiac diseases?
VISTAQ provides a highly reproducible, time-efficient, contour-less method for LGE quantification that demonstrates superior prognostic discrimination in hypertrophic cardiomyopathy compared to conventional threshold-based techniques.
Answers are grounded in this paper and cite their sources.
May enhance LGE-based risk stratification in HCM; extends quantification methods but leaves open prospective validation.
Background Late gadolinium enhancement (LGE) quantification by cardiovascular magnetic resonance is central to risk stratification in hypertrophic cardiomyopathy (HCM), yet conventional techniques require contour tracing and region-of-interest (ROI) placement, which may reduce reproducibility and increase analysis time. We developed a novel visual standardized approach, the Visual Standardized Quantification of LGE (VISTAQ), that does not require myocardial contouring, arbitrary ROI positioning, or dedicated post-processing software. Methods In this multicenter, multivendor retrospective study, LGE images from 400 patients (100 prior myocardial infarction, 250 HCM, 50 other non-ischemic heart diseases) were analyzed. VISTAQ subdivides each myocardial segment into transmural mini-segments and classifies LGE visually using predefined criteria, expressing global LGE burden as the percentage of positive mini-segments. Reproducibility was assessed in 250 patients across different observer expertise levels using intraclass correlation coefficients (ICC) and Bland–Altman analysis. In 100 HCM patients, VISTAQ was compared with conventional methods (mean+2SD, +5SD, +6SD, FWHM, visual thresholding). Prognostic performance was evaluated in 250 HCM patients over a median 5-year follow-up. Results VISTAQ demonstrated excellent intra- and inter-observer reproducibility (ICC up to 0.98 and 0.97, respectively), consistent across disease subtypes. Compared with conventional techniques, VISTAQ showed similar ICC to FWHM but significantly lower net and absolute inter-observer differences (median absolute difference 1.3%). Mean+2SD markedly overestimated LGE, whereas mean+6SD slightly underestimated LGE compared with VISTAQ, mean+5SD, FWHM, and visual thresholding. Analysis time was substantially shorter with VISTAQ (median 105 vs. 375 seconds, p<0.0001). During follow-up, 21 hard cardiac events occurred in HCM population. An LGE threshold >10% predicted events with higher accuracy using VISTAQ (AUC 0.90; sensitivity 85%; specificity 94%) compared with mean+6SD (AUC 0.75; sensitivity 57%; specificity 93%). Conclusions VISTAQ provides highly reproducible, time-efficient LGE quantification without dedicated software and demonstrates non-inferior prognostic discrimination in HCM compared with conventional threshold-based techniques.
No takes yet. Share an insight, caveat, or question.
Aquaro et al. (2026) conducted a cohort in Hypertrophic cardiomyopathy, prior myocardial infarction, non-ischemic heart disease (n=400). Visual Standardized Quantification of LGE (VISTAQ) vs. Conventional threshold-based techniques (mean+6SD) was evaluated on Hard cardiac events (cardiac death, resuscitated cardiac arrest, appropriate ICD shock, antitachycardia pacing, sustained ventricular tachycardia) (HR 56, 95% CI 19-163, p=<0.0001). VISTAQ quantification of late gadolinium enhancement >10% predicted hard cardiac events in hypertrophic cardiomyopathy with an HR of 56, demonstrating superior prognostic discrimination compared to conventional threshold-based techniques.
Synapse has enriched 10 related papers. Consider them for comparative context: